Avivagen Developing Products to Replace Antibiotics in Livestock, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - July 13, 2016) - CEO of Avivagen (TSXV: VIV), Cameron Groome talks about this company is developing products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease.

If you cannot view the video above, please visit:
http://www.b-tv.com/avivagen-ceo-clip/

Theralase Technologies Inc. is being featured on CBC's Documentary Channel, Jul 25 - Aug 7, 2016, Monday through Friday, throughout the day and evenings.

Avivagen (TSXV: VIV)

Avivagen Inc. is a life sciences company developing scientifically-proven products for replacing antibiotics in livestock feeds and to otherwise benefit human and animal health. Avivagen is based in partnership facilities of the National Research Council of Canada (NRC) - in Ottawa, Ontario and Charlottetown, Prince Edward Island. http://www.avivagen.com/

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in the US and Canada.  These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: Thomson Reuters, BNN.ca, and Stockhouse.com.  They are also disseminated via a video news release to several financial portals including Globe Investor, OTC Markets, TMX Money, and The National Post.

BTV - Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com